Academic Journal

PD13-11 ADDITIONAL NOVEL CYTOREDUCTIVE TREATMENTS TO THE PRIMARY TUMOUR AND METASTASIS FOR DE NOVO METASTATIC-HORMONE SENSITIVE PROSTATE CANCER (IP2-ATLANTA): THE INTERNAL PILOT OUTCOMES OF A PHASE II, MULTICENTRE, RANDOMISED CONTROLLED TRIAL

Bibliographic Details
Title: PD13-11 ADDITIONAL NOVEL CYTOREDUCTIVE TREATMENTS TO THE PRIMARY TUMOUR AND METASTASIS FOR DE NOVO METASTATIC-HORMONE SENSITIVE PROSTATE CANCER (IP2-ATLANTA): THE INTERNAL PILOT OUTCOMES OF A PHASE II, MULTICENTRE, RANDOMISED CONTROLLED TRIAL
Authors: Martin J. Connor, Taimur T. Shah, Johanna Sukumar, Dolan Basak, Francesca Fiorentino, Catherine Heath, Gail Horan, Nicholas Johnson, Vincent Khoo, Bijan Khoubehi, Natalia Klimowska-Nassar, Stephen Mangar, John McGrath, Consuelo Nohpal De La Rosa, Derek Price, Bhavan Rai, Naveed Sarwar, Smith Andrew, John N. Staffurth, Kamalran Thippu Jayaprakash, Mathias Winkler, Tim Dudderidge, Hashim U. Ahmed
Source: Journal of Urology. 213
Publisher Information: Ovid Technologies (Wolters Kluwer Health), 2025.
Publication Year: 2025
Document Type: Article
Language: English
ISSN: 1527-3792
0022-5347
DOI: 10.1097/01.ju.0001109880.25183.6b.11
Accession Number: edsair.doi...........e2ed3c32b6cfa68ca48cb0aa12bc893d
Database: OpenAIRE
Description
ISSN:15273792
00225347
DOI:10.1097/01.ju.0001109880.25183.6b.11